Publishers' Bookfair Opens
Registration/Course Enrollment Opens
Industry-Supported Symposia
IS1. New Augmentation Strategies in Depression for Better
Outcomes
Supported by GlaxoSmithKline
IS2. Strategies for Maintaining Wellness in Patients With Bipolar
Disorder: Moving Beyond Efficacy to EffectivenessSupported by
Bristol-Myers Squibb Company and Otsuka America Pharmaceutical, Inc.
IS3. Navigating the Maze: Understanding Methods, Results, and Risks in
Psychiatric ResearchSupported by Forest Laboratories, Inc.
IS4. Bridging Sleep Science and Public PolicySupported by
Takeda Pharmaceuticals North America, Inc.
Industry-Supported Symposia
IS5. Mania in Special PopulationsSupported by Shire US,
Inc.
IS6. Verging on Reality: Emergent Therapeutic Approaches for
SchizophreniaSupported by Bristol-Myers Squibb Company and Otsuka
America Pharmaceutical, Inc.
IS7. Bipolar Disorder: Creating a Consensus From Science to Public
PolicySupported by Solvay Wyeth Pharmaceuticals
IS8. Treatment-Resistant Depression: New Data, New ApproachesSupported by Cyberonics, Inc.